GOLO’s Release Supplement

Case Name
Bubak et al v. GOLO, LLC
21-cv-492, E.D. Cal.
(March 2021)
Product/Service GOLO’s Release Supplement
Allegations Implying that the supplement mitigates and prevents diabetes, heart disease, and Alzheimer’s disease by claiming that it is “the Natural Solution to Insulin Resistance”

Misleadingly marketing the supplement as “Clinically Proven” when the company relies on pilot studies that it paid for and that have not been peer reviewed or published in legitimate scientific publications

Status Pending
Print Friendly, PDF & Email


Leave a Reply

Back to Top ↑
  • Search Class-Action Tracker

  • Recent Class Actions

  • The Class-Action Tracker is intended to notify consumers about false advertising class-action lawsuits filed around the country, but does not necessarily reflect TINA.org’s opinion with respect to the lawsuits or disposition of the cases

  • Sign Up for E-mail Updates